About: Opioid substitution therapy with buprenorphine-naloxone during COVID-19 outbreak in India: Sharing our experience and interim standard operating procedure

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Opioid substitution therapy with buprenorphine-naloxone during COVID-19 outbreak in India: Sharing our experience and interim standard operating procedure Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Opioid substitution therapy with buprenorphine-naloxone during COVID-19 outbreak in India: Sharing our experience and interim standard operating procedure
Creator	Ghosh, Abhishek Basu, Debasish Mattoo, S. Subodh, B.
Source	Medline; PMC
abstract	Coronavirus disease 2019 (COVID-19) has been declared as a pandemic by the World Health Organization on March 11, 2020. It has affected most countries of the world, including India. Both the disease and the unavoidable national response to it have posed unique challenges to our health-care system. A particular vulnerable group of patients is those with opioid dependence maintained on opioid substitution therapy (OST). These patients are pharmacologically dependent on the OST medication (buprenorphine, buprenorphine-naloxone combination [BNX], and methadone) for their healthy functioning and recovery. COVID-19 outbreak, lock-down, and difficult access to medical care, all are likely to induce stress and withdrawal, which is a potential risk for relapse among individuals with opioid dependence, who are anyway more vulnerable due to social, housing, living, and medical conditions. In this context, it is essential to re-strategize the existing OST services to adapt to the challenging circumstances. In this communication, we share our experience and formulate interim standard operating procedures (SOPs) for running a hospital-based OST service utilizing take-home BNX. The challenges, principles to meet the challenges, and interim SOPs are shared as being currently practiced in our center. Individual institutes, agencies, hospitals, and clinics running OST service with BNX can adapt these SOPs according to their characteristics, needs, demand, and resources; so long as, the basic principles are adhered to.
has issue date	2020-05-15(xsd:dateTime)
bibo:doi	10.4103/psychiatry.indianjpsychiatry_295_20
bibo:pmid	32773878
has license	cc-by-nc-sa
schema:url	https://doi.org/10.4103/psychiatry.indianjpsychiatry_295_20
resource representing a document's title	Opioid substitution therapy with buprenorphine-naloxone during COVID-19 outbreak in India: Sharing our experience and interim standard operating procedure
has PubMed Central identifier	PMC7368441
has PubMed identifier	32773878
schema:publication	Indian J Psychiatry
resource representing a document's body	covid:PMC7368441#body_text
is schema:about of	named entity 'buprenorphine' named entity 'anxiety' named entity 'OST' named entity 'social distancing' named entity 'COVID' named entity 'relapse' named entity 'OST' named entity 'OST' named entity 'lockdown' named entity 'OST' named entity 'WHO' named entity 'coronavirus' named entity 'socioeconomic' named entity 'sublingual tablets' named entity 'buprenorphine' named entity 'preventive measures' named entity 'Chandigarh' named entity 'COVID-19 outbreak' named entity 'health-care professionals' named entity 'opioids' named entity 'Drug Dependence' named entity 'NACO' named entity 'social-distancing' named entity 'access to medical care' named entity 'lock-down' named entity 'COVID' named entity 'OST' named entity 'methadone' named entity 'PGIMER' named entity 'COVID-19' named entity 'medication dispensing' named entity 'nursing staff' named entity 'viral transmission' named entity 'COVID-19' named entity 'health-care' named entity 'OST' named entity 'working from home' named entity 'COVID-19 outbreak' named entity 'PGIMER' named entity 'opioids' named entity 'OST' named entity 'agonist' named entity 'OST' named entity 'informed consent' named entity 'nursing staff' named entity 'Psychiatry' named entity 'National AIDS Control Organization' named entity 'OST' named entity 'Europe' named entity 'Treatment Clinics' named entity 'IDUs' named entity 'AIIMS' named entity 'controlled substances' named entity 'epidemics' named entity 'OST' named entity 'mode of transmission' named entity 'government of India' named entity 'methadone' named entity 'Postgraduate Institute of Medical Education and Research' named entity 'Emergency Medical' named entity 'IDUs' named entity 'OST' named entity 'COVID-19 outbreak' named entity 'curfew' named entity 'All India Institute of Medical Sciences' named entity 'OST' named entity 'union territories' named entity 'medical conditions' named entity 'buprenorphine' named entity 'outpatient' named entity 'OST' named entity 'COVID-19' named entity 'OST' named entity 'Treatment Clinics' named entity 'OST' named entity 'lockdown' named entity '8:30' named entity 'community transmission' named entity 'opioid-dependent'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software